Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 Guide - Dosing, Benefits, Research & Clinical

Mechanism of Action BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from human gastric juice. It exerts its effects through multiple pathways including upregulation of growth factor expression (EGF, FGF, VEGF), modulation of the nitric oxide system, activation of the FAK-paxillin pathway for cell migration, and promotion of tendon fibroblast growth. BPC-157 has demonstrated cytoprotective properties across virtually every organ system studied. Clinical Applications Gastrointestinal healing (ulcers, IBD, leaky gut) Tendon and ligament repair Muscle injury recovery Neuroprotection and brain injury Wound healing acceleration Inflammatory bowel disease NSAID-induced damage reversal Periodontal healing Dosing Protocols Typical subcutaneous dosing: 250-500mcg once or twice daily. Oral dosing for GI applications: 250-500mcg twice daily on empty stomach. Treatment cycles typically run 4-8 weeks. Safety & Side Effects BPC-157 has shown an excellent safety profile in an

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Mechanism of Action

BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide derived from human gastric juice. It exerts its effects through multiple pathways including upregulation of growth factor expression (EGF, FGF, VEGF), modulation of the nitric oxide system, activation of the FAK-paxillin pathway for cell migration, and promotion of tendon fibroblast growth. BPC-157 has demonstrated cytoprotective properties across virtually every organ system studied.

Clinical Applications

Gastrointestinal healing (ulcers, IBD, leaky gut) Tendon and ligament repair Muscle injury recovery Neuroprotection and brain injury Wound healing acceleration Inflammatory bowel disease NSAID-induced damage reversal Periodontal healing

Dosing Protocols

Typical subcutaneous dosing: 250-500mcg once or twice daily. Oral dosing for GI applications: 250-500mcg twice daily on empty stomach. Treatment cycles typically run 4-8 weeks.

Safety & Side Effects

BPC-157 has shown an excellent safety profile in animal studies with no reported LD50. Common side effects are minimal and may include mild injection site reactions. No significant drug interactions have been identified in preclinical research.

Clinical Information

Category: Regenerative Type: Peptide Profile Audience: Healthcare Providers & Clinicians Evidence Level: Clinical research and peer-reviewed studies Source: Peptide Education Hub — The Most Comprehensive Evidence-Based Peptide Resource

Related Peptides

TB-500 (Thymosin Beta-4) GHK-Cu KPV Pentosan Polysulfate

Get a Personalized BPC-157 Protocol

Dr. Peptide AI generates evidence-based BPC-157 protocols by integrating genetic analysis, lab data, predictive analytics, and collective practitioner intelligence. Get personalized dosing, cycling, and monitoring recommendations. Talk to Dr. Peptide AI

Explore More Peptide Education

Peptide Education Hub provides comprehensive, evidence-based peptide education for healthcare providers. Browse our complete library of 109+ peptide profiles, clinical tools, and training resources.

A-Z Peptide Index Peptide Blends & Formulas Clinical Tools Training & Education Research Studies Latest Articles

Connected topics

Follow this recovery question